[1] |
You Yonghong1, Zheng Suhua, Xie Yanguang, Yang Yingzhou, Wang Xiaomeng, Li Fabin, Tan Weiguo, Liao Ziping, Duanmu Hongjin.
Clinical observation of therapy for pulmonary tuberculosis patient with rifampicin resistance
[J]. Chinese Journal of Antituberculosis, 2009, 31(6): 363-367.
|
[2] |
Cao Wenli, Xu Qingjie, Kang Lijun, Li Aling, Xiang Xi, Wu Junfeng, Shi Liheng.
Analysis of drug resistance of patients with tuberculosis hospitalized in Beijing Geriatric Hospital
[J]. Chinese Journal of Antituberculosis, 2009, 31(6): 331-333.
|
[3] |
Lu Tanwang, Zhang Lei, Long Weijun, Zhao Meigui, Wen Guihua, Chen Wensheng.
Analysis on trend failure tendency of new smear positive TB cases in Bao’an district, Shenzhen from 2002 to 2006
[J]. Chinese Journal of Antituberculosis, 2009, 31(6): 321-322.
|
[4] |
Tan Weiguo1, Deng Weizhong1, Zhao Meigui2, Guan Hongyun1,Yang Yingzhou1.
Evaluation on management and treatment of MDR-TB patients in Shenzhen
[J]. Chinese Journal of Antituberculosis, 2009, 31(5): 256-258.
|
[5] |
Chen Genwang, Wang Jixiang, Zhang Genyou, Wu Ying.
Analysis on case-finding and treatment outcome of pulmonary tuberculosis patients in Anhui from 2002 to 2007
[J]. Chinese Journal of Antituberculosis, 2009, 31(3): 132-134.
|
[6] |
Zeng Dan,Yu Delu,Tian Jingfang.
Clinical observation of the therapeutic effect with capreomycin ultrasonic aerosol inhalation combined with antitubercular agents in the treatment of retreated sputum positive pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2009, 31(1): 3-5.
|
[7] |
Weng Lizhen,Zhu Yufang,Chen Shuqin,et al..
Clinical observation on the clinical efficacy of compound Glycyrrhizin in the treatment of new pulmonary tuberculosis complicated with chronic hepatitis B
[J]. Chinese Journal of Antituberculosis, 2007, 29(5): 419-422.
|
[8] |
Cheng Shiming1,Zhong Qiu,Zheng Jinfeng.et al..
Operational research of use Fixed-Dose Combination in national tuberculosis programme in China
[J]. Chinese Journal of Antituberculosis, 2007, 29(2): 111-116.
|
[9] |
Tan Weiguo1,Yang Yingzhou,Wu Qingfang,et al..
Comparison analysis on Fixed-dose Combination and blister pack drug in treating tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2007, 29(2): 117-121.
|
[10] |
Wang Qingfeng,Gao Mengqiu,Ma Liping,et al..
A clinical observation on treatment effect of rifapentine for rifampin resistant pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2006, 28(6): 382-384.
|
[11] |
Wang Xuejing,Wu Guiying,Duan Mu Hongjin,et al..
Explore the causes of prior irregular treatment among re-treatment pulmonary TB cases in TB Control Project Areas
[J]. Chinese Journal of Antituberculosis, 2006, 28(4): 209-211.
|
[12] |
Lin Zhilai,Shi Zhenhui,Weng Heng,et al..
Clinical observation on the clinical efficacy and safety of the regimen of ’Pasiniazid Rifapentine Amikacin and Levofloxcin’ for lesions of the liver caused by tuberculosis
[J]. Chinese Journal of Antituberculosis, 2006, 28(4): 238-240.
|
[13] |
He Yonghong1,Cheng Shiming,Chen Cheng.
Survey and analysis on the compliance of fixed-dose combination on TB treatment
[J]. Chinese Journal of Antituberculosis, 2006, 28(3): 129-132.
|
[14] |
Ge Qiping,Gao Weiwei,Kong Zhongshun,et al..
Therapeutic effect and safety of three different regimens to 103 eldly new pulmonary tuberculosis inpatients with smear-positive
[J]. Chinese Journal of Antituberculosis, 2006, 28(3): 152-155.
|
[15] |
Zeng Lixiang,Chen Bingxi,Li Yafa,et al..
Evaluation on the the short-term effects of chemotherapy for the patients with tuberculosis and diabetes
[J]. Chinese Journal of Antituberculosis, 2006, 28(2): 74-76.
|